April 20, 2022
Two years ago, Sangeeta Bhatia and Christopher Chen founded a biotech company that on Wednesday officially launched as Satellite Bio in Cambridge, Massachusetts. The company aims to translate the work of Bhatia, Chen and their cofounder Arnav Chhabra into "tissue therapeutics" — regenerative medicines built from bioengineered tissue structures, or "satellites," that can be implanted into patients. Source: BiopharmaDive